tiprankstipranks
Advertisement
Advertisement

GNNSF Stock Latest News

Genscript Biotech Shareholders Approve All Resolutions at 2026 AGM
Company AnnouncementsGenscript Biotech Shareholders Approve All Resolutions at 2026 AGM
8d ago
Genscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives
PremiumCompany Announcements
Genscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives
8d ago
Genscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma
PremiumCompany Announcements
Genscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma
10d ago
Genscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs
PremiumCompany Announcements
Genscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs
11d ago
GenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting
PremiumCompany Announcements
GenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting
22d ago
Genscript flags Legend Biotech Q1 results and cautions investors on risk
PremiumCompany AnnouncementsGenscript flags Legend Biotech Q1 results and cautions investors on risk
1M ago
Genscript Highlights Strong Q1 2026 CARVYKTI Sales via Legend Biotech
Premium
Company Announcements
Genscript Highlights Strong Q1 2026 CARVYKTI Sales via Legend Biotech
2M ago
Genscript Biotech Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
Premium
Company Announcements
Genscript Biotech Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
2M ago
Genscript Biotech Proposes Governance Overhaul to Align With Updated Listing Rules
PremiumCompany Announcements
Genscript Biotech Proposes Governance Overhaul to Align With Updated Listing Rules
2M ago
Genscript Biotech Names New Company Secretary and Authorised Representative
PremiumCompany Announcements
Genscript Biotech Names New Company Secretary and Authorised Representative
3M ago
Genscript Biotech’s Core Earnings Surge but Legend Impairment Drives 2025 Net Loss
PremiumCompany Announcements
Genscript Biotech’s Core Earnings Surge but Legend Impairment Drives 2025 Net Loss
3M ago
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
PremiumCompany Announcements
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
3M ago
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
PremiumCompany AnnouncementsGenscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
3M ago
Genscript Biotech Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Genscript Biotech Sets March Board Meeting to Approve 2025 Annual Results
3M ago
Genscript Chairman Joins Board of Nasdaq-Listed Associate Legend Biotech
Premium
Company Announcements
Genscript Chairman Joins Board of Nasdaq-Listed Associate Legend Biotech
5M ago
Genscript Highlights Strong Q4 2025 CARVYKTI® Sales Reported by Legend Biotech
PremiumCompany Announcements
Genscript Highlights Strong Q4 2025 CARVYKTI® Sales Reported by Legend Biotech
5M ago
Genscript Biotech Grants Share Awards to Directors
PremiumCompany Announcements
Genscript Biotech Grants Share Awards to Directors
6M ago
Genscript Biotech Updates RSU Schemes for Improved Governance
PremiumCompany Announcements
Genscript Biotech Updates RSU Schemes for Improved Governance
6M ago
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
PremiumCompany Announcements
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
6M ago
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
PremiumCompany AnnouncementsGenscript Biotech Announces Q3 2025 Results for Legend Biotech
7M ago
Genscript Biotech’s Associate to Present New Data at Hematology Meeting
Premium
Company Announcements
Genscript Biotech’s Associate to Present New Data at Hematology Meeting
7M ago
Genscript Biotech Reports Strong CARVYKTI® Sales in Q3 2025
Premium
Company Announcements
Genscript Biotech Reports Strong CARVYKTI® Sales in Q3 2025
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >